Introduction
Myelodysplastic syndromes (MDS) are a group of heterogeneous diseases in which a hypercellular bone marrow contrasts with peripheral blood cytopenias. The percentage of blast cells in the bone marrow, the number of cytopenias and the presence or absence of cytogenetic abnormalities distinguish low-grade from high-grade MDS. 1 A characteristic feature of low-grade MDS is the excessive apoptosis of hematopoietic precursors in the bone marrow. 2 Apoptotic bone marrow cells demonstrate activated caspases, together with phosphatidylserine exposure at their surface and nuclear DNA fragmentation. 3 Caspaseindependent apoptosis through mitochondrial release of apoptosis-inducing factor and endonuclease G and autophagy in nutrient depletion conditions could also account for death of dysplastic cells in other lineages. 4, 5 We and others have explored the mechanism of apoptosis in erythroid precursors deriving from low-grade MDS CD34 þ bone marrow cells by ex vivo culture. 6, 7 These cells activate a so-called 'extrinsic pathway' to death, starting at the level of the death receptor Fas (APO-1, CD95) at the cell surface. 8 Upon stimulation, this receptor recruits the adapter protein Fasassociated death domain (FADD) that in turn recruits and activates the initiator caspase-8 in the death-inducing signaling complex (DISC). The death receptor Fas and its ligand, FasL, are overexpressed at the surface of low-grade MDS erythroid precursors. 6, 8, 9 An excess of soluble Fas or the ectopic expression of a dominant-negative mutant of FADD prevents caspase activation and apoptosis in low-grade MDS erythroid precursors derived from bone marrow CD34 þ progenitors by liquid culture. 10 How Fas is connected to downstream apoptotic events in MDS erythroid precursors remains poorly known. Depending on the cell type, caspase-8 activated at the DISC level either directly activates effector caspase and/or cleaves Bid, a BH3-only protein of the Bcl-2 family whose truncated form connects the extrinsic to an intrinsic, mitochondria-dependent, pathway to death. 11 In this latter pathway, the release of cytochrome c from mitochondria, which is negatively regulated by antiapoptotic proteins of the Bcl-2 family, leads to the assembly of the apoptosome, a cytosolic, multimolecular platform on which caspase-9 is recruited and activated to initiate a caspase cascade leading to death. An increase in mitochondrial membrane permeability (MMP) and a cytosolic release of cytochrome c have been observed in low-grade MDS bone marrow cells, suggesting that the mitochondria were involved in their apoptosis, 12 but whether these events are connected to Fas is unknown.
Another cellular organelle that can play a role in apoptosis, including Fas-mediated apoptosis, is the endoplasmic reticulum (ER). 13, 14 ER-mediated apoptosis involves Ca 2 þ -dependent 14, 15, 16 and -independent mechanisms. 17, 18 At physiological levels, Ca 2 þ released from the ER is taken up by the mitochondria to stimulate oxidative phosphorylation and adenosine-5'-triphosphate (ATP) production. In some circumstances, a rapid extrusion of Ca 2 þ from ER stores can initiate apoptosis through the mitochondrial Ca 2 þ overload. 14 One of the mechanisms by which Bcl-2 and Bcl-x L , which are expressed at the ER level, protect cells from apoptosis is the depletion of ER Ca 2 þ stores that prevents the exit of high Ca 2 þ levels. 15, 19, 20 ER-mediated apoptosis is also associated with changes in ER proteins such as the Bcl-2-associated protein (BAP) 31 17, 21 and caspase-4. 18, 22 Active caspase-8 cleaves BAP31 to generate a fragment that triggers mitochondrial cell death. 21 Caspase-8-induced cleavage of BAP31 could connect Fas activation to mitochondrial events, 13 indicating that the ER could participate as an intermediate organelle in death receptorinduced apoptosis in some cell types.
The present study explores the role of the ER in apoptosis of low-grade MDS erythroid precursors. By contrast to Bcl-x L , 23 the expression of Bcl-2 strongly decreases along erythroid differentiation in normal and MDS erythroid precursors. We transduced CD34
þ bone marrow progenitors with either wildtype Bcl-2 (WT-Bcl-2) construct, whose product is expressed at both the mitochondria and the ER, or an ER-targeted construct (ER-Bcl-2), 24 before inducing their erythroid differentiation in liquid medium. We show that WT-Bcl-2 and the ER-targeted construct both inhibit spontaneous and Fas-induced apoptosis in MDS erythroid precursors. We demonstrate that the ER controls MDS erythroid cell apoptosis upstream of the mitochondria. Further exploration of the Fas death pathway identifies the caspase-8-mediated cleavage of BAP31 as a characteristic event in MDS erythroid precursors undergoing spontaneous apoptosis.
Patients, materials and methods

Patients and controls
A total of 28 patients with low-grade MDS were tested, including 17 with refractory anemia (RA) or refractory cytopenia and 11 with RAEB with less than 10% blast cells, as referred to the WHO classification. All patients and volunteers were informed and gave their consent according to the recommendations of the local ethics committee. RA with ringed sideroblasts were excluded because of severe impairment of mitochondria due to iron overload. 7, 12 All patients were at diagnosis or received only supportive care with blood transfusion. MDS and normal bone marrow samples from volunteers (n ¼ 10) were obtained by sternal aspiration. Normal CD34 þ cells were also purified from peripheral blood cytapheresis (n ¼ 5). Due to limited cell availability, all parameters could not be analyzed in each sample.
Materials
The reagents used for culture were Iscove's modified Dulbecco's medium (IMDM), serum-free substitute BIT 9500 (Stem Cell Biotechnology, Vancouver, Canada), b-mercaptoethanol, dexamethasone, glutamine, streptomycin and penicillin (all from Sigma-Aldrich, St Louis, MO, USA). Recombinant human erythropoietin (rHuEpo) and stem cell factor (SCF) were generous gifts from Amgen (Thousand Oaks, CA, USA), insulin was purchased from Bayer (Leverkunsen, Germany) and rHu insulin-like growth factor (IGF)-1 was from Sigma-Aldrich. Lonidamine, thapsigargin, b1,1 0 ,3,3,3 0 ,3 0 -hexamethylindodicarbo-cyanine iodide (HIDC), propidium iodide (PI), carbonyl cyanide m-chlorophenylhydrazone (CCmClP), and 4,6-diamidino-2-phenyl indole (DAPI) were purchased from Sigma-Aldrich, and 7-aminoactinomycin D (7-AAD), mitotracker Red, Fura-2/acetomethyl ester (AM) were from Molecular Probes (Irvine, CA, USA). Agonist Fas antibodies (clone CH11) were from Beckman Coulter (Miami, FL, USA). Rabbit polyclonal antibodies to Bcl-2 were from Santa-Cruz Biotechnology (Santa-Cruz, CA, USA) and to calreticulin from Affinity Bioreagents (Golden, CO, USA). The mouse monoclonal antibody to cytochrome c was from BD Pharmingen (Franklin Lakes, NJ, USA). Chicken and rabbit polyclonal antibodies to BAP31 were a generous gift from Dr GC Shore (McGill University, Montreal, Quebec, Canada). The mouse monoclonal antibody to Hsc70 was from Santa-Cruz Biotechnology. The mouse monoclonal antibodies to actin, to FLAG and the human control immunoglobulin M (IgM) were from Sigma-Aldrich. Cell permeant inhibitor of caspase-8 z-Iso-GluThr-Asp (IETD)-fmk was from Calbiochem (Darmstadt, Germany).
Cell culture and stimulation
For erythroid cell expansion, CD34 þ cells were isolated from the mononuclear cell fraction of bone marrow samples or cytapheresis products using the MidiMacs system (Miltenyi Biotec, Bergisch Gladbach, Germany). CD34 þ cells, which purity was higher than 85%, were cultured at 0.5 Â 10 6 per ml for 14 days in IMDM containing 20% BIT 9500, b-mercaptoethanol 10 À4 M, penicillin/streptomycin, sodium bicarbonate 1.9 mM, rHuEpo 1 UI/ml, SCF 50 ng/ml, IGF-1 40 ng/ml and dexamethasone 10 À6 M. Cells were diluted every 2 days in the same medium until day 10. From days 10 to 14, cells were switched to Epo (1 UI/ml) and insulin (1 UI/ml) to obtain terminal erythroid differentiation. 8 At day 5 of the liquid culture, cells (10 000 per ml) were seeded in methylcellulose medium containing Epo (1 UI/ml), SCF (50 ng/ml), IL-3 (0.3 UI/ml), IL-6 (10 ng/ml) and granulocyte colony-stimulating factor (5 ng/ml). Erythroid progenitors of burst forming unit-erythroid (BFU-E) type were counted at day 10 of the semisolid culture. In some experiments, erythroid cells (1 Â 10 6 per ml) harvested between days 10 and 14 of the culture were stimulated with 500 ng/ml Fas agonist antibody CH11 or control IgM in the presence or absence of z-IETD-fmk at indicated times. As a control of ER targeting, hematopoietic cell line U937 was used and treated with 5 mM thapsigargin for 16 h as an inducer of ER stressdependent apoptosis.
Lentiviral constructs and cell transduction
Flag-tagged human WT-Bcl-2 and flag-tagged human Bcl-2 selectively localized to the ER by exchanging the COOHterminal transmembrane sequence of Bcl-2 for the transmembrane domain of the ER protein cytochrome b5 (ER-Bcl-2) were kindly provided by Dr VM Dixit (Genentech, San Francisco, CA, USA). They were cloned in the pTripDU3EF1a lentiviral vector upstream an IRES ECMV -green fluorescent protein (GFP) cassette. Infectious vector particles were produced in 293T cells by transient co-transfection with the p8.91-and the VSV-Gencoding plasmids. The empty vector devoid of insert was used as control. Lentivirus transduction was performed twice at days 0 and 1. Due to the limited number of purified CD34 þ cells, five MDS and three control samples were transduced with WTBcl-2 and control vectors only.
Flow cytometry
Transduction efficacy was measured as the percentage of GFPpositive cells (FL1). Bcl-2 expression was followed by intracellular fluorescence of the PE-Bcl-2 monoclonal antibody (FL2). For cell-cycle analysis, cells were fixed in 1% paraformaldehyde, permeabilized with 70% ethanol for 1 h at À20 1C and then labeled with 1 mg/ml PI in the presence of 20 ml RNAse at 10 mg/ml for 30 min at room temperature. Cell-cycle-oriented 
Immunofluorescence
For immunofluorescence studies, erythroid precursors were spread on glass slides by cytocentrifugation. Cytochrome c was detected as followed: cells were fixed in 4% paraformaldehyde and permeabilized in 0.1% saponin containing PBS. Cells were stained with a mouse monoclonal anti-cytochrome c antibody, followed by Alexa 568 coupled goat anti-mouse secondary antibody. Results were expressed as percentage of cells with diffuse cytochrome c labeling among 100 cells for each condition. WT-Bcl-2 or ER-Bcl-2 was detected with the monoclonal anti-FLAG antibody. Immune complexes were visualized using cyanine 5-conjugated goat anti-mouse antibody (Jackson ImmunoResearch, West Grove, PA, USA). Mitochondria were stained with Mitotracker Red. Calreticulin, as a marker of ER was stained with a rabbit polyclonal antibody and revealed by an Alexa 568-conjugated goat anti-rabbit antibody (Molecular Probes). Nuclei were colored with DAPI. Fluorescence images were obtained on a Leica DMB microscope and analyzed using the Metamorph software (Molecular Devicer Corp, Dowington, PA, USA).
Caspase activities
Caspase-3 like activities were determined using a fluorometric assay. Cells were incubated in lysing buffer (150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate) for 30 min at 4 1C and clarified by centrifugation (10 000 g, 20 min, 4 1C). Proteins (30 mg) were incubated in 100 mM HEPES (pH 7.0), 1 mM ETDA, 0.1% CHAPS, 10% glycerol, 20 mM dithiothreitol, in the presence of 100 mM fluorogenic peptide substrate the Ac-Asp-Glu-Val-Asp (DEVD)-7-amino-4-methylcoumarin (AMC) for caspase-3 and related enzymes (Calbiochem). AMC released from the substrate was excited at 380 nm to measure emission at 460 nm. Fluorescence was monitored continuously at 37 1C for 30 min in a dual luminescence fluorometer MicroTek OS (Bio-Tek Kontron Instruments, Winooski, VT, USA). Caspase activities were determined as initial velocities expressed as relative intensity of fluorescence per minute per milligram.
Spectrofluorimetry for Ca 2 þ measurement
Endoplasmic reticulum (ER) and cellular Ca 2 þ concentrations were measured with the use of the fluorescent probe Fura-2/AM. Cells (1 Â 10 6 cells per ml) were loaded with 1 mM Fura-2/AM at 37 1C in the dark for 20 min, washed and resuspended in saline buffer (140 mM NaCl, 5 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 11 mM glucose, 10 mM HEPES, pH 7.4). EGTA (10 mM) was added as an extracellular Ca 2 þ chelator immediately before stimulation with 100 nM thapsigargin. Dual excitation alternating at 340 mm and 380 nm was provided by a Cary Eclipse spectrofluorimeter (Varian, Les Ulis, France), equipped with two excitation monochromators and emission was measured at 510 nm. Fluorescence ratio R ¼ F 380 /F 340 was recorded every 3 s for around 5 min at 37 1C. Results were expressed as the rate of Ca 2 þ exit that is the initial slope (first derivative) of calcium rise upon thapsigargin treatment.
Western blot
Cells at days 10-14 were solubilized in HEPES 50 mM (pH 7.4), NaCl 150 mM, Triton X-100 0.5% containing protease inhibitors for 20 min on ice and then lysed in Laemmli buffer. Proteins were analysed by SDS/polyacrylamide gel electrophoresis and transferred to nitrocellulose membrane for immunoblot analysis. Membrane were saturated in 5% low fat milk for 2 h at room temperature and incubated with 1 mg/ml primary monoclonal antibody at 4 1C overnight and with horseradish peroxidase-coupled secondary antibody. Specific labeling was revealed by ECL chemiluminescence kit (General Electric Healthcare, Bucks, UK).
Statistical analysis
Values are expressed as means±s.e.m. Continuous variables were compared using the Student's t-test and P-values o0.05 were considered statistically significant.
Results
Ectopic expression of WT-Bcl-2 and ER-Bcl-2 in normal and MDS erythroid precursors
To determine whether the ER was involved in apoptosis of lowgrade MDS erythroid precursors, we transduced MDS or control bone marrow CD34 þ cells with a lentiviral vector encoding WT-Bcl-2 or ER-Bcl-2. The corresponding c-DNAs, fused to a FLAG tag, were under the control of EF1a promoter. The vectors also encoded the GFP under the control of an IRES. The percentage of GFP-expressing cells 7 days after transduction ranged from 65 to 91%. An anti-FLAG antibody detected a 28 kDa (WT-Bcl-2) or a 30 kDa (ER-Bcl-2) band in erythroid cells obtained after 10 days of liquid culture of transduced CD34 þ cells. Endogenous Bcl-2 remained equally expressed in all transduced cells, whatever the vector used ( Figure 1a Figure 1c ). These observations confirmed that ER-targeted Bcl-2 was expressed at the ER level and specifically inhibited apoptotic pathways involving the ER.
ER-targeted Bcl-2 inhibits spontaneous and Fasdependent apoptosis of MDS erythroid precursors
Apoptosis markers were analyzed in GFP þ erythroid precursors. For example, at day 14 of liquid culture, the basal level of annexin V þ /7-AAD À cells in normal samples (n ¼ 7) was 9.8±3.5%. Expression of WT-or ER-targeted Bcl-2 did not affect this basal level in normal samples. A spontaneous increase in the percentage of annexin V þ /7-AAD À cells was observed in MDS samples (n ¼ 18, 16.8 ± 6.4%) and was completely suppressed by both constructs (Po0.05; Figure 2a ). WT-and ER-targeted Bcl-2 also significantly decreased the Ac-DEVD-AMC cleavage activity, suggesting that caspase-3 activation in MDS erythroid precursors (n ¼ 4; Po0.05), which was not observed in normal samples (n ¼ 4; Figure 2b ) was inhibited.
Ectopic expression of WT-and ER-Bcl-2 in normal and MDS CD34 þ bone marrow cells did not significantly affect cell growth (Supplementary Figure 1A) . The quantification of GFP þ cells at days 7, 10 and 14 demonstrated that WT-Bcl-2-or ER-Bcl-2-transduced cells had no growth advantage over nontransduced cells (data not shown). Erythroid progenitors of BFU-E type were quantified at day 5 of the liquid culture as previously described. 8 The ratio of BFU-E in cultures transduced with WT-Bcl-2 over empty vector was equivalent in MDS (n ¼ 4) and control samples (n ¼ 4) (Supplementary Figure 1B) . To understand why Bcl-2 expression does not increase cell proliferation although it prevents cell death, we performed cell-cycle analysis of erythroid cells at day 7 of the culture. The percentage of S-phase cells decreased in erythroid cultures transduced with WT-Bcl-2 compared to the control vector, indicating that Bcl-2 delayed cell-cycle entry in erythroid cells, as observed in transgenic mice and other tissue culture models. 25, 26 In agreement, WT-and ER-Bcl-2 delayed the differentiation of both normal and MDS erythroid precursors as demonstrated by lower expression of glycophorin A (Supplementary Figure 1D ) and increased percentage of proerythroblast and basophilic erythroblast cytological analysis (Supplementary Figure 1E) . Altogether, these results demonstrate the pure antiapoptotic effect of Bcl-2 that increases erythroid cell survival but does not induce cell proliferation.
We have previously shown that MDS erythroid precursors overexpressed Fas receptor and were responsive to Fas-induced cell death, even in the presence of Epo, 8, 11 whereas normal erythroid precursors were responsive to Fas-dependent cell death in the absence of Epo. 27 Here, we show that ER-targeted Bcl-2 is as efficient as WT-Bcl-2 to prevent apoptosis induced by Fas engagement with an anti-Fas agonistic antibody (CH11) in MDS erythroid precursors cultured with Epo (Figure 2c) . Thus, this first series of experiments suggests an important role for the ER in apoptosis of MDS erythroid precursors.
ER-Bcl-2 inhibits the mitochondrial pathway to apoptosis
We then observed that both transgenes significantly prevented the increase in HIDC low /PI À MDS erythroid precursors at day 14 Figure 3c ). We conclude from these experiments that the ER might play a role in the spontaneous and Fas-involving apoptosis of MDS erythroid precursors, upstream of the mitochondria.
ER Ca 2 þ stores are increased in MDS erythroid precursors
To further understand the importance of the ER in the spontaneous apoptosis of MDS erythroid precursors, we first explored the Ca 2 þ storage and homeostasis in these cells. Normal and MDS erythroid precursors at day 10 of the culture were loaded with the Ca 2 þ dye Fura-2/AM and stimulated with the inhibitor of SERCA pumps, thapsigargin. Experiments were performed in the presence of EGTA as a chelator of extracellular Ca 2 þ . The rise of Ca 2 þ (F 380 /F 340 ) induced by thapsigargin reflected ER Ca 2 þ pools (Figure 4a ). Treatment of Fura-2/ AM-loaded cells with thapsigargin indicated that ER Ca 2 þ stores were increased in MDS compared to normal samples (Figure 4a , left panel). Ca 2 þ exit from the ER, represented by the initial slope (first derivative) of the Ca 2 þ rise upon thapsigargin exposure, occurred much faster in MDS (n ¼ 5) than in normal (n ¼ 4) erythroid precursors (Po0.05; Figure 4a , right panel).
Bcl-2 was proposed to reduce the amount of Ca 2 þ releasable from the ER by increasing ER Ca 2 þ leak, thus preventing mitochondrial Ca 2 þ overload and cell death in response to various stimuli. 15, 19, 20 A homogeneous population of GFP þ erythroid precursors was selected by cell sorting, loaded with Fura-2/AM and stimulated with thapsigargin in the presence of EGTA. As expected, expression of WT-and ER-Bcl-2 in normal erythroid precursors significantly decreased the ER Ca 2 þ stores, as demonstrated by exposure to thapsigargin (n ¼ 4; Figure 4b ; Po0.05). Surprisingly enough, such an effect was not observed in MDS erythroid cells, that is neither WT-nor ER-Bcl-2 modified ER Ca 2 þ stores measured by the efflux provoked by exposure to thapsigargin (n ¼ 4; Figure 4b ). Altogether, these 
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experiments demonstrate an increase in ER Ca 2 þ stores in MDS compared to normal erythroid precursors. They also indicate that the protective effect of ER-targeted Bcl-2 toward spontaneous apoptosis of MDS erythroid precursors cannot be explained by a Bcl-2-induced leak of ER Ca 2 þ stores.
BAP31 protein is cleaved in MDS erythroid precursors undergoing apoptosis
To further explore the importance of the ER in MDS erythroid precursor apoptosis, we examined the expression of BAP31, a protein whose cleavage was specifically associated with ERmediated apoptosis. 13, 17 Immunoblot experiments detected BAP31 in U937 cells as well as in MDS (n ¼ 10) and control (n ¼ 5) erythroid precursors. Exposure of U937 cells to thapsigargin induced the appearance of a p20 BAP31 fragment (Figure 5a) . A similar p20 BAP31 fragment was identified in all the tested MDS samples, suggesting cleavage of the protein in a fraction of the cells (Figure 5a ). Both WT-and ER-targeted Bcl-2 decreased apoptosis of MDS erythroid precursors and the associated cleavage of BAP31 into a p20 fragment (Figure 5b) . These experiments indicated that cleavage of the ER-associated BAP31 protein might be related to apoptosis occurring spontaneously in MDS erythroid precursors.
To further demonstrate the link between apoptosis and BAP31 cleavage in these cells, we inhibited caspase-8 activity with increasing concentrations of z-IETD-fmk (Figure 6a ). Z-IETD-fmk inhibited both BAP31 cleavage into a p20 fragment and MDS cell apoptosis. To investigate whether Fas engagement could trigger BAP31 cleavage in MDS erythroid precursors, we exposed these cells to 500 ng/ml Fas agonistic antibody CH11 for 16 h (Figure 6b ). CH11 enhanced the generation of the BAP31 cleavage fragment p20 in MDS erythroid precursors, which was prevented by z-IETD-fmk (Figure 6b) . At the end, we checked in four MDS samples that all the steps of the described Fas-caspase-8-BAP31-mitochondria pathway could be identified and modulated by ER-targeted Bcl-2 in CD34 þ -derived erythroid cells.
To test the protective effect of rHuEpo against spontaneous and Fas-induced apoptosis in MDS, we added increasing amounts of Epo to the culture of MDS precursors during the stimulation by CH11 for 16 h (Figure 6c ). Epo addition partially inhibited spontaneous and CH11-induced BAP31 cleavage, as well as cell apoptosis. Altogether, these experiments indicate Endoplasmic reticulum in MDS apoptosis E Gyan et al that both spontaneous and Fas-stimulated MDS erythroid cell apoptosis are associated with a caspase-8-mediated BAP31 cleavage at the ER level, and can be inhibited by increasing doses of Epo in the culture.
Discussion
Apoptosis of erythroid precursors is one of the pathophysiological events that account for anemia in low-grade MDS. We showed previously that the deregulated expression of the death receptor Fas and its ligand at the cell surface was at least in part responsible for apoptosis of dysplastic erythroid lineage in RA or RAEB-1. 8, 10 Whether disease-associated changes in the apoptotic pathways exist downstream of Fas receptor in MDS erythroid cells remained unknown. By specifically expressing Bcl-2 at the ER level, we show here that the ER is a component of the pathway leading from Fas engagement to mitochondrial changes and apoptosis of erythroid precursors in low-grade MDS.
We also show that Ca 2 þ stores are spontaneously increased in the ER as compared to normal cells. Nevertheless, ER-targeted Bcl-2 does not induce ER Ca 2 þ leak as observed in normal cells, which suggests alterations of ER Ca 2 þ homeostasis in these cells. The ER-associated protein BAP31 is shown to be cleaved in MDS erythroid precursors, downstream of caspase-8 activation. These results indicate a central role for ER in MDS erythroid cell apoptosis, downstream of Fas and upstream of the mitochondria.
Several nonlethal functions of caspases have been identified, including a role in red cell differentiation. 28, 29, 30 Caspase activation is increased in MDS compared to normal erythroid precursors undergoing differentiation. 3 Death of low-grade MDS erythroid precursors cannot be viewed as an amplification of the physiological caspase-3 activation that contributes to normal erythroid differentiation because this physiological pathway does not involve Fas or caspase-8. 29, 30 It remains to be demonstrated whether apoptosis of MDS erythroid precursors could be the consequence of the deregulation of the negative loop that controls normal erythropoiesis through Fas and caspase-8. 
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E Gyan et al Spontaneous apoptosis of MDS erythroid precursors was associated with an increase in MMP and a cytosolic release of cytochrome c. 12 The connection between Fas and the mitochondria remained to be established. The usual connection involves the caspase-8-mediated cleavage of the BH3-only protein Bid. 11 We failed to reproducibly identify a cleavage of this protein in MDS erythroid cell precursors undergoing apoptosis (data not shown). Although less well defined, another connection between death receptors and the mitochondria involves the ER, which propagates the death induced by other stress signals such as Ca 2 þ , ceramide and protein unfolding. 15, 16, 31 Several proteins of the Bcl-2 family are expressed at the ER level and modulate ER-mediated cell death. 15, 19, 20 By overexpressing ER-targeted Bcl-2, we inhibited apoptosis, MMP and cytochrome c release as efficiently as when WT-Bcl-2 or Bcl-x L (data not shown) were overexpressed in MDS erythroid precursors, which ascertains the implication of the ER in the control of the mitochondrial pathway of apoptosis in these cells. Whether caspase-independent death pathway exist in MDS erythroid cells as in megakaryocytes 4 and could be blocked in ER-targeted Bcl-2 remains a matter of speculation.
One of the mechanisms by which Bcl-2 and related proteins modulate apoptosis at the ER level is the regulation of ER Ca 2 þ concentration. Bcl-2 interacts with inositol 1,4,5-triphosphate receptors (InsP3R) to provoke ER Ca 2 þ leak. The subsequent decrease in ER Ca 2 þ concentration prevents the release of large amounts of Ca 2 þ and subsequent apoptosis upon ER stress. 32, 33 Here, we show that ER-targeted Bcl-2 decreases ER Ca 2 þ stores in normal erythroid precursors and protect these cells from apoptosis. Surprisingly, this effect was not identified in MDS erythroid precursors. In these latter cells, Ca 2 þ homeostasis appears to be impaired with enhanced Ca 2 þ stores in the ER and Bcl-2 does not induce any leakage of ER Ca 2 þ . Mechanisms that could account for this observation include either altered InsP3R expression, or deregulated interaction of InsP3R with post-translationally modified Bcl-2 or with activated Bax and Bak. 34, 35 In preliminary experiments using real-time reverse transcription PCR, we did not detect any change in InsP3RI, II and III transcripts in MDS erythroid precursors (data not shown), which does not rule out functional defect in the InsP3R proteins. Further study is currently done to understand which changes at the ER level account for abnormal Ca 2 þ storage and regulation in MDS erythroid precursors. Ca 2 þ disturbances may stimulate adaptative responses to protect the cells from death, for example, by triggering autophagy that ensures the turnover of macromolecules and ATP production in injured cells and can lead to cell death. This process is inhibited by ER-targeted, not by mitochondrial Bcl-2. 36 At least in some cell types, ER stress leading to apoptosis can implicate the cleavage of caspase-4, and downregulation of caspase-4 expression by small-interfering RNA renders these cells resistant to ER stress-induced apoptosis. 18, 37, 38 Caspase-4 activation was shown to account for spontaneous death of human plasma cells. 22 Although we detected a cleavage of caspase-4 into a p35 fragment in erythroid precursors from most studied patients with MDS ( Supplementary Figure 2) , this cleavage was inconstantly modulated by ER-targeted Bcl-2 (data not shown), suggesting that caspase-4 cleavage might not play a central role in the spontaneous death of these cells. Consistent with our data, a previous study demonstrated that ER stress did not induce the cleavage of caspase-4 in a MDS cell line. 39 Nevertheless, together with the enhanced ER Ca 2 þ stores, this observation argues for a deregulation of several ER functions in MDS erythroid precursors. Another ER-associated protein linked to ER stress-induced cell death is the Bcl-2-associated protein, BAP31. We here report that the ability of ER-targeted Bcl-2 to prevent spontaneous apoptosis of MDS erythroid precursors correlates with its ability to prevent the cleavage of BAP31. Overexpression of WT-Bcl-2 was previously shown to prevent BAP31 cleavage in epithelial cells undergoing apoptosis. 21 BAP31, which is part of a large ERanchored complex that regulates the export of membrane and secreted proteins, can be cleaved by activated caspase-8. 17, 21, 37 The p20 fragment generated by this cleavage promotes mitochondrial events leading to apoptosis such as cytochrome c release, and BAP31 cleavage connects Fas engagement to mitochondrial events in epithelial and breast cancer cells. 13, 17 Our data demonstrate that BAP31 cleavage in MDS erythroid precursors undergoing spontaneous apoptosis is prevented by a caspase-8 inhibitor and can be amplified by exposure of these cells to an anti-Fas agonistic antibody, which correlates with enhanced apoptosis. In addition to the pro-apoptotic role of the 20 kDa fragment of BAP31, the cleavage of this protein could affect its functions at the ER level. These functions include the export of several tetraspanins that contribute to the maintenance of functional b1 integrins at the cell surface, 40 thus promote erythroid cell survival. 41 Interestingly, integrin adhesion to fibronectin has shown to be defective in MDS bone marrow cells. 42 Erythropoietin is used in clinical practice for treatment of low-grade MDS patients, as it allows correction of anemia and À cells) (b) MDS erythroid precursors at day 10 of the culture were stimulated with 500 ng/ml CH11 for 16 h with or without 20 mM z-IETD-fmk before immunoblot analysis of BAP31 (Hsc70: loading control) and apoptosis measurement (percentage of annexin V þ /7-AAD À cells). In both panels, one representative of three independent experiments is shown. (c) MDS erythroid precursors at day 10 were washed, and cultured for 16 h with fresh medium containing 0, 1 or 10 UI/ml Epo, and stimulated or not with 500 ng/ml CH11 before immunoblot analysis of BAP31 (Hsc70: loading control) and apoptosis measurement (percentage of annexin V þ /7-AAD À cells) was performed.
Endoplasmic reticulum in MDS apoptosis E Gyan et al transfusion independence in anemic patients (review in Hellströ m-Lindberg and Malcovati 43 ), and increased survival. 44 In this study, we observe a protective effect of increasing doses of Epo on the Fas-induced apoptosis of MDS precursors, as well as a decrease of the cleavage of the ER protein BAP31. This is consistent with the known anti-apoptotic effect of Epo on erythroid cells. The spontaneous apoptosis of erythroid precursors that characterizes low-grade MDS and leads to anemia, involves the deregulated expression of death receptors and their ligands. Our data demonstrate a role for the ER, downstream of Fas, in the pathway leading to death, possibly through caspase-8-mediated cleavage of BAP31. They also demonstrate several alterations in the functions of the ER, such as deregulated Ca 2 þ storage and spontaneous cleavage of caspase-4. Thus, together with excessive death receptor-dependent apoptosis and genetic instability, changes in ER functions could play a role in MDS dyserythropoiesis.
